We present a TALEN-based workflow to generate and maintain dual-edited (IL-15+/+/TGFβR2−/−) iPSCs that produce enhanced iPSC-derived natural killer (iNK) cells for cancer immunotherapy. This evidence concerns the gene TGFBR2 and cancer.